These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32944779)

  • 1. Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study.
    Ogata Y; Fujieda Y; Sugawara M; Sato T; Ohnishi N; Kono M; Kato M; Oku K; Amengual O; Atsumi T
    Rheumatology (Oxford); 2021 Mar; 60(3):1331-1337. PubMed ID: 32944779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study.
    Qi W; Zhao J; Huang C; Jiang N; Li J; Wu C; Zhang S; Hu C; Xu D; Wang Q; Li M; Tian X; Zhao Y; Zeng X
    Arthritis Res Ther; 2022 Jun; 24(1):140. PubMed ID: 35690831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
    Guedon AF; Ricard L; Laurent C; De Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Boffa JJ; Cohen A; Wahl C; Abisror N; Maillot F; Fain O; Mekinian A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of damage in different clusters of patients with antiphospholipid syndrome.
    Uludağ Ö; Çene E; Gurel E; Çetin Ç; Bektaş M; Yalçınkaya Y; Diz-Küçükkaya R; Gül A; Inanç M; Artim-Esen B
    Lupus; 2022 Apr; 31(4):433-442. PubMed ID: 35166607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study.
    Laurent C; Ricard L; Nguyen Y; Boffa JJ; Rondeau E; Gerotziafas G; Elalamy I; Deriaz S; De Moreuil C; Planche V; Johanet C; Millot F; Fain O; Mekinian A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 37001919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and prognosis of elderly-onset antiphospholipid syndrome: An observational cohort study.
    Luo L; Cai Q; Liu X; Yun Z; Li X; Yan R; Li C
    Lupus; 2024 Sep; 33(10):1034-1042. PubMed ID: 39033374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests.
    Ottavi M; Toulon P; Casolla B; Martis N
    Front Immunol; 2024; 15():1361062. PubMed ID: 38440737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
    Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
    Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
    Nguyen Y; Yelnik CM; Morel N; Paule R; Stammler R; Plaçais L; Sacré K; Godeau B; Maillard H; Launay D; Morell-Dubois S; Dupré A; Lefèvre G; Devloo C; Dufrost V; Benhamou Y; Levesque H; Leroux G; Piette JC; Mouthon L; Hachulla É; Lambert M; Le Guern V; Costedoat-Chalumeau N
    Rheumatology (Oxford); 2023 Aug; 62(8):2813-2819. PubMed ID: 36190346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
    Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D
    Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.
    Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Haj Yahia S; Ellis MH; Agmon-Levin N
    Front Immunol; 2022; 13():843718. PubMed ID: 35514968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response.
    Saraiva Sda S; Custódio IF; Mazetto Bde M; Collela MP; de Paula EV; Appenzeller S; Annichino-Bizzachi J; Orsi FA
    Thromb Res; 2015 Dec; 136(6):1174-8. PubMed ID: 26601900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study.
    Pardos-Gea J; Marques-Soares JR; Buján S; Ordi-Ros J; Alijotas-Reig J
    Rheumatology (Oxford); 2022 Mar; 61(3):1053-1061. PubMed ID: 34115832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological characteristics of antiphospholipid syndrome in an Asian population: a retrospective study.
    Jatuworapruk K; Bhoopat L; Hanvivadhanakul P
    Asian Pac J Allergy Immunol; 2019 Sep; 37(3):171-178. PubMed ID: 29981567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].
    Oku K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):435-441. PubMed ID: 29367527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.